bankruptcy Court Approves Genapsys Sale to Sequencing Health According to the asset purchase agreement, Sequencing Health would offer up to $10 million in cash and assume Genapsys debt of approximately $32 million. Genapsys Founders Lose Bid to Dismiss Bankruptcy Case Genapsys has also obtained a minimum bid for its assets worth approximately $42 million, including $10 million in cash and the assumption of debt. Genapsys Files for Chapter 11 Bankruptcy Protection The Redwood City, California-based sequencing firm laid off more than 70 employees on July 8 after furloughing nearly all of its employees in late June. Sequencing Firm Genapsys, Mired in Lawsuits, Explores Bankruptcy Premium The lawsuits are not the only recent disruption for Genapsys, which laid off approximately 40 employees earlier this year after a $70 million financing in 2021. uBiome Files for Chapter 7 Liquidation The company had previously declared Chapter 11 bankruptcy, which would have enabled it to reorganize to stay afloat and pay its creditors over time. Sep 4, 2019 uBiome Declares Bankruptcy, Offers Assets for Sale Jul 23, 2018 Vela Diagnostics Accelerates Entry Into US Microbiology Market With Great Basin Buy Premium Jun 4, 2018 Rosetta Genomics Files for Chapter 7 Bankruptcy May 31, 2018 3D Signatures Lays Off Employees, Will Declare Bankruptcy Jun 26, 2017 Eurofins to Acquire Genoma May 12, 2017 Premaitha Vows to Recover $970K From Bankrupt Swiss Customer Genoma, Take Over NIPT Business Apr 14, 2017 NanoMolecular DX Purchases Nuclea's Assets for $330K Premium Mar 17, 2017 Nuclea's Former CEO Attempting to Buy Company's Assets in Bankruptcy Dec 21, 2016 Nuclea to Auction Assets as Part of Chapter 7 Bankruptcy Proceedings Premium Sep 16, 2015 Bankruptcy Court Approves True Health Dx's $37.1M Bid for HDL's Assets Sep 11, 2015 True Health Dx Set to Buy HDL's Assets for $37.1M Sep 4, 2015 True Health Submits $32M Stalking Horse Bid for HDL Jul 31, 2015 Currently in Chapter 11, Natural Molecular Testing Will Shut Down, Repay CMS $71M Oct 17, 2013 US Subsidiary of ZyGem Shuttered After Forced Bankruptcy; Questions Surround Asset Disbursement Premium Jun 17, 2013 Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche Mar 11, 2013 Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company Jan 31, 2013 Marina Defaults on Loan as Bankruptcy Looms Premium Dec 12, 2012 Synthetic Bio Firm GeneForge Files for Chapter 7 Bankruptcy Nov 16, 2012 Helicos BioSciences Files for Chapter 11 Bankruptcy Protection Oct 18, 2012 Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials Premium Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.